Brief: Biolidics Says COVID-19 Antibody Test Kits Gets Relevant Authorisation From Health Ministry In Indonesia
Nov 26 (Reuters) - Biolidics Ltd BIOL.SI :
* ANTIBODY TEST KITS OBTAINED RELEVANT AUTHORISATION FROM
MINISTRY
OF HEALTH IN INDONESIA FOR DISTRIBUTION & USE
* AUTHORISATION REMAINS VALID UNTIL 25 NOVEMBER 2021
* COVID-19 ANTIBODY TEST KITS OBTAINED RELEVANT
AUTHORISATION FROM
MINISTRY OF HEALTH IN INDONESIA FOR DISTRIBUTION & USE
Source text for Eikon: ID:nSNZ7dsfQN
Further company coverage: BIOL.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Embracing Future Holdings
See all newsBrief: Embracing Future To Buy 10% Of Embracing Future Biomedical For S$6.7 Million
Brief: Biolidics Posts FY Pretax Profit SGD -3.187 Million
Brief: Biolidics Ltd To Acquire Shenzhen Xiaozhao Network Technology
Brief: Biolidics Announces Resignation Of Song Tang Yih As Executive Director And CEO
Brief: Biolidics Announces Cybersecurity Incident